APRICONA

This brand name is authorized in Nigeria.

Active ingredients

The drug APRICONA contains one active pharmaceutical ingredient (API):

1	Fluconazole UNII 8VZV102JFY - FLUCONAZOLE
	Fluconazole is a triazole antifungal agent. Its primary mode of action is the inhibition of fungal cytochrome P-450-mediated 14 alpha-lanosterol demethylation, an essential step in fungal ergosterol biosynthesis.
	Read more about Fluconazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-0932	Tablet	APRICONA 150MG TABLETS TAB 150 mg 1 X 10	69 RNW-PP-169602 APRICONA 150MG TABLETS FLUCONAZOLE Microcrystalline cellulose, Povidone, Calcium Phosphate Dibasic, Magnesium Stearate, Sodium Starch Glycolate, B4-0932 Drugs ANTIINFECTIVES FOR SYSTEMIC USE Imported Products 110 Prescription Only Medicine (POM) 12/13/2021 VITBORAH PHARM COMPANY LIMITED, LAYI OYEKANMI STREET , MUSHIN ISOLO LAGOS 7036395409 vitborahpharma@gmail.com BRUSSELS LABORATORIES PVT LTD, NO. 33, CHANGODAR INDUSTRIAL ESTATE, SARKEJ- BAVLA ROAD, CHANGODA-382210 DIS AHMEDABAD, GUJARAT,INDIA., India	28/03/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J02AC01	Fluconazole	J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AC Triazole and tetrazole derivatives
Discover more medicines within J02AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-0932